218 related articles for article (PubMed ID: 35612708)
1. Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers.
Heinig R; Nagelschmitz J; Loewen S
Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):549-559. PubMed ID: 35612708
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies.
Lentini S; Heinig R; Kimmeskamp-Kirschbaum N; Wensing G
Fundam Clin Pharmacol; 2016 Apr; 30(2):172-84. PubMed ID: 26604072
[TBL] [Abstract][Full Text] [Related]
3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
4. An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton's Tyrosine Kinase Inhibitor.
Cheng Y; Liu L; Xue Y; Zhou S; Li Y
Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):579-592. PubMed ID: 35657581
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
6. The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects.
Anderson K; Zheng H; Kotecha M; Cuvin J; Scott B; Sharma S; Qin AR; Namour F; Xin Y
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):585-594. PubMed ID: 30768860
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of different formulations of oral azacitidine (CC-486) and the effect of food and modified gastric pH on pharmacokinetics in subjects with hematologic malignancies.
Laille E; Savona MR; Scott BL; Boyd TE; Dong Q; Skikne B
J Clin Pharmacol; 2014 Jun; 54(6):630-9. PubMed ID: 24374798
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
Wang M; Wang M; Zhang Q; Zong S; Lv C
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese Volunteers.
Xu M; Wang Y; Wang X; Pu Z; Liu Y; Jiang C; Shen X; Sun H; Xie H
Drugs R D; 2024 Mar; 24(1):41-50. PubMed ID: 37985605
[TBL] [Abstract][Full Text] [Related]
10. Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3.
Heinig R; Fricke R; Wertz S; Nagelschmitz J; Loewen S
Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):803-815. PubMed ID: 36029368
[TBL] [Abstract][Full Text] [Related]
11. Phase I crossover study of DNA-protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension.
Becker A; Krebs-Brown A; Vetter C; Reuter T; Rodriguez-Gutierrez A; You X; Lissy M
Clin Transl Sci; 2023 Dec; 16(12):2628-2639. PubMed ID: 37905356
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
13. Single-dose clinical pharmacokinetic studies of gefitinib.
Swaisland HC; Smith RP; Laight A; Kerr DJ; Ranson M; Wilder-Smith CH; Duvauchelle T
Clin Pharmacokinet; 2005; 44(11):1165-77. PubMed ID: 16231967
[TBL] [Abstract][Full Text] [Related]
14. Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects.
Patel MR; Kansagra KA; Parikh DP; Parmar DV; Patel HB; Soni MM; Patil US; Patel HV; Patel JA; Gujarathi SS; Parmar KV; Srinivas NR
Clin Drug Investig; 2018 Jan; 38(1):57-65. PubMed ID: 29022212
[TBL] [Abstract][Full Text] [Related]
15. Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.
Morcos PN; Moreira SA; Navarro MT; Bech N; Quatkemeyer A; Smith PF; Brennan BJ
J Pharm Pharmacol; 2014 Jan; 66(1):23-31. PubMed ID: 24117531
[TBL] [Abstract][Full Text] [Related]
16. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
Kinzler ER; Pantaleon C; Iverson M; Aigner S
Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
Shaik N; Hee B; Wei H; LaBadie RR
Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Food on Tramadol and Celecoxib Bioavailability Following Oral Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label, Single-Dose, Crossover Study in Healthy Volunteers.
Encina G; Encabo M; Escriche M; Lahjou M; Sicard E; Smith K; Gascon N; Plata-Salamán C; Videla S
Clin Drug Investig; 2018 Sep; 38(9):819-827. PubMed ID: 30008052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
